MERCK & CO., INC. (MRK)
Clinical trial NCT06956235 updates: 1. completion date: 2029-01-22 → 2028-06-06 2. primary completion date: 2026-11-16 → 2026-04-02 3. enrollment: 147 → 149 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06956235 updates: 1. completion date: 2029-01-22 → 2028-06-06 2. primary completion date: 2026-11-16 → 2026-04-02 3. enrollment: 147 → 149 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical